Sep 7, 2016 | Digital Pathology, Instruments & Equipment, Laboratory Pathology, Laboratory Testing
Oak Ridge National Laboratory sees potential for clinical laboratories and pathology groups to control disease and assess treatments
What do you get by blending microscopy with mass spectrometry? A new multi-tasking tool for studying disease progression and response to treatments in patients.
Combining these two technologies into a single device could also have uses for clinical laboratory scientists and pathologists. However, much research must be done before such a device is ready to obtain FDA clearance for use in clinical settings by the nation’s medical laboratories.
The new device was created by researchers at Oak Ridge National Laboratory (ORNL) in Oak Ridge, Tenn. They created an imaging system that supplies microscopy with spatially resolved chemical analyses.
This new development will be of high interest to surgical pathologists who work with microscopes and clinical chemists who currently perform mass spectrometry testing. It shows how one research effort has the potential to bring together two technologies regularly used in laboratory medicine. (more…)
Nov 2, 2012 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations
Once completed, this merger would bring two nationally- respected departments of pathology and clinical laboratory into the combined health system
Two of the nation’s most prominent academic departments of pathology and clinical laboratory medicine will become part of a single “super-health system” if a just-announced plan to merge takes place. In Detroit on Wednesday, it was announced that Henry Ford Health System and Beaumont Health System had each signed a letter of intent to merge.
CEO Nancy Schlichting of Henry Ford Health System and CEO Gene Michalski, of Beaumont Health System discussed the plan to merge their health systems at a press conference on Wednesday, October 31. The deal is subject to further discussions and due diligence. No target date for completion of the merger was provided. (more…)
Oct 24, 2011 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Shortage of pathologists only adds to the challenges of providing high quality anatomic pathology testing services
DATELINE: Hangzhou, China—More than 1,200 Chinese pathologists and medical laboratory scientists assembled this weekend in a city marked by 1,500 years of history. The occasion was the first-ever combined meeting of the Chinese Society of Pathology and the Pathology Branch of the Chinese Medical Association.
Across the globe, pathologists and clinical laboratory professionals regularly hear about the rapid economic growth in China. This country is modernizing at an astounding rate and the evidence is easy to see in its major cities. That is certainly true here in Hanghzou, which has a population of 8.7 million people and is the anchor city for Zhejiang Province, with a population of approximately 54.4 million. It has many new buildings in its downtown and construction cranes are visible in every direction.
(more…)
Oct 16, 2009 | Instruments & Equipment, Laboratory Pathology
Are digital whole slide imaging systems ready to replace conventional light microscopy for diagnostic surgical pathology?
Next week, an FDA committee will consider whether to allow pathologists to use digital pathology systems for primary diagnosis. Even if the committee does not make a positive recommendation, the timing demonstrates the swift progress in the quality of digital pathology images and the systems that present them to the pathologists.
Digital pathology imaging systems are slowly replacing microscopes in the nation’s clinical labs. There is now enough momentum in the market for digital pathology imaging that the FDA’s Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee will meet October 22 and 23 in Gaithersburg, Maryland, to hear from experts in digital imaging. (See agenda) The FDA review committee may later make recommendations on the public health issues related to the use of digital whole slide imaging systems to replace conventional light microscopy for diagnostic surgical pathology.
(more…)
Jan 27, 2009 | Digital Pathology, Laboratory News, Laboratory Operations, Laboratory Pathology, News From Dark Daily
How much longer will anatomic pathologists spend the majority of their time in a quiet office, viewing glass slides through a microscope? Will radiologists and pathologists soon collaborate on diagnosing the patient and jointly releasing an integrated patient report to the referring physician?
Should you think these scenarios are several years into the future, you may be surprised to learn that first-mover pathology groups and radiology groups are in the earliest stages of fully-digital (non-glass) pathology and collaborative diagnosis/patient reporting. These pathologists and radiologists will tell you that this is an exciting time and they are advancing patient care because of these innovations.
At University of Kansas, an extraordinary collaboration was launched last summer involving Ossama W. Tawfik, M.D., Ph.D., Director of Anatomic and Surgical Pathology and his colleague; Mark L. Redick, M.D., Assistant Professor of Radiology, University of Kansas. Tawfik and Redick began meeting regularly to jointly review selected breast cancer cases. “It was quickly obvious to us both that, by reviewing each other’s primary clinical data together, there were immediate benefits to the referring physician and the patient,” noted Tawfik. “We’ve learned two things from this collaboration. First, there have been few changes in the diagnostic aspect of the cases we review. Second, on the treatment side, our pathology/radiology integration is driving significant changes in how the patient receives treatment and what therapies are recommended.”
Tawfik and Redick are speaking about their in vivo/in vitro collaboration at the upcoming Molecular Summit on the Integration of In Vivo and In Vitro Diagnostics in Philadelphia on February 10-11, 2009. Location is the Sheraton Society Hill Hotel in Philadelphia, Pennsylvania.
At Molecular Summit 2009, the future of the glass slide versus an all-digital pathology service will be discussed by CEOs from industry-leading firms such as Aperio Technologies, Inc., BioImagene, Inc., and DMetrix, Inc.. One sure sign that pathologists are adopting slide scanning and digital pathology systems is the accelerating rate of sales of digital systems reported by these three companies during the past 24 months.
Pathologists and radiologists wanting to stay at the top of their game and profit from the opportunities unfolding in personalized medicine and vivo/in vitro integration should register to attend Molecular Summit 2009. This year’s top-flight event has a distinguished faculty of 27 international experts and covers the spectrum of advanced molecular diagnostics, imaging, and informatics. Unique case studies provide attendees with everything they need to know to advance their molecular skills and tap new sources of patient referrals and income.
Register today and guarantee your place at this important event for pathology and radiology! The full agenda and speaker line-up for Molecular Summit 2009 on February 10-11 can be viewed here (or paste this URL into your browser: http://www.molecular-summit.com/program.htm )
Visit http://www.molecular-summit.com
Download Full Program Brochure
Four Easy Ways to Register:
1. Register ONLINE
2. Call 800-560-6363. Our friendly staff can register you quickly and easily, as well as answer any questions you may have.
3. Fax this complete registration form to 512-264-0969
4. Mail the one page register form with payment to:
THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
